Breaking the Barriers: How Gender Equity Advances Immunisation

LOOK AT THIS IF YOU'RE INTERESTED IN:

Understanding more about gender equity and how it relates to immunisation.

HOW YOU CAN USE THIS MATERIAL:

The evidence in this Featured Issue can be used as a tool to advocate to policymakers and decision makers on the importance of gender equity, how equity relates to immunisation, and how it impacts immunisation coverage and zero-dose.

OVERVIEW:

The COVID-19 pandemic has highlighted and exacerbated existing global gender inequities that impact the accessibility of immunisations to women and children worldwide, influencing their access to health services, education, and economic opportunities. Gender-related inequities contribute to barriers to immunisation for people of all genders. Although girls and boys in most settings are equally likely to be vaccinated, evidence has found that advancing global gender equity can play an important role in ensuring all children have access to vital health resources such as immunisation. This VoICE Featured Issue summarizes key evidence on gender equity and its impact on immunisation and zero-dose.

You May Also Like

Scoping Review of Current Costing Literature on Interventions to Reach Zero-Dose Children in Low- and Middle-Income Countries

A study in Vaccines analyzes the costs and effectiveness of interventions aimed at reaching zero-dose children—those who have not received any routine vaccinations—in low- and middle-income countries (LMICs). The research evaluates strategies such as mobile outreach, community engagement, and health system strengthening, highlighting their cost-effectiveness in improving immunisation coverage. The findings suggest that tailored, context-specific … Read More

Socioeconomic-related inequities in child immunisation: horizontal and vertical dimensions for policy insights

A study in Health Economics Review investigates the economic and equity impacts of expanding immunisation programs in low- and middle-income countries (LMICs), focusing on the cost-effectiveness of introducing new vaccines. The research highlights that while scaling up immunisation efforts requires significant investment, the long-term benefits—such as reduced disease burden, healthcare savings, and improved productivity—justify the … Read More